Mechanism of renal dysfunction in the early phase of telaprevir therapy in combination with peginterferon-alfa2b and ribavirin

• SAKANE Sadatsugu

  Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital

• SAKAKIBARA Yuko

  Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital

• YOSHIO Toshiyuki

  Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital

• NAKAZURU Shoichi

  Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital

• TOYAMA Takashi

  Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital

• ISHIDA Hisashi

  Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital

• MITA Eiji

  Department of Gastroenterology and Hepatology, National Hospital Organization, Osaka National Hospital

Bibliographic Information

Other Title

• Telaprevir/Peginterferon-alfa2b/Ribavirin 併用療法導入直後の腎機能低下機序に関する検討

Journal

• 肝臓

  肝臓 53 (7), 434-435, 2012-07-25

Keywords

• telaprevir
• adverse event
• renal dysfunction

Details

• CRID: 1570291225822943232
• NII Article ID: 10030950466
• NII Book ID: AN00047770
• ISSN: 04514203
• Text Lang: ja
• Data Source:
  • CiNii Articles